A detailed history of Pender Fund Capital Management Ltd. transactions in Profound Medical Corp. stock. As of the latest transaction made, Pender Fund Capital Management Ltd. holds 9,400 shares of PROF stock, worth $70,688. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,400
Previous 7,300 28.77%
Holding current value
$70,688
Previous $61,000 21.31%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.47 - $11.18 $15,687 - $23,478
2,100 Added 28.77%
9,400 $74,000
Q2 2024

Aug 14, 2024

BUY
$7.25 - $9.07 $52,925 - $66,211
7,300 New
7,300 $61,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Pender Fund Capital Management Ltd. Portfolio

Follow Pender Fund Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pender Fund Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pender Fund Capital Management Ltd. with notifications on news.